Back

Patient-reported outcome measures following pulsed-field ablation versus thermal ablation of atrial fibrillation: results of the prospective PROMs-PFA study

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Outcomes of pulsed field ablation in atrial fibrillation (2) Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Mark Mills

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Efficacy and safety of pulsed-field ablation in atrial fibrillation patients with high versus low comorbidity burden: a multicenter analysis
Ms E. Roth (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Impact of pulsed field ablation on outcome in obese patients undergoing pulmonary vein isolation for atrial fibrillation
Ms K. Yang (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Lesion characteristics after atrial fibrillation ablation using pulsed field ablation
Doctor M. Foti (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Pulsed field ablation for pulmonary vein isolation and additional lesion set in patients with persistent atrial fibrillation: safety, efficacy and long-term outcome from a nationwide experience
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Pulsed field ablation for pulmonary vein isolation in atrial fibrillation: comparison between mapping integrated and non integrated 3D mapping systems
Doctor L. Rossi (Piacenza, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes of pulsed field ablation in atrial fibrillation (2)

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Atrial fibrillation: ablation 3
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)
thumbnail
Congress Session
Pulsed field ablation for atrial fibrillation ablation: latest findings

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources